2Bonnet F,Cooper ME.Potential influence of lipids in diabetic nephropathy:insights from experimental data and clinical studies[J].Diabetes Metab,2000,26(4):254-264.
5Inman SR,Stowe NT,Cressman MD,et al.Lovastatin preserves renal function in experimental diabetes[J].Am J Med Sci,1993,317(4):215-221.
6Tonolo G,Ciccarese M,Brizzi P,et al.Reduction of albumin excretion rate in normotensive microalbuminuric type 2 diabetic patients during long-term simvastatin treatment[J].Diabetes Care,1997,20(12):1891-1895.
2PICKUP J C,CROOK M A.Is type II diabetes mellitus a disease of innate immune system?[J].Diabetologia,1998,41(10):1241-1248.
3PHILIP A,SUBRAMANIAN R,CHUNLING L,et al.Adipose tissue tumor necrosis factor and interleukin-6,expression in obesity and insulin resistance[J].Am J Physiol Endocrinol Metab,2001,280(5):E745-E751.
4HRNCIAR J,GARBOR D,HRNCIAROVA M,et al.Relation between cytokine (TNF-alpha,IL-6 and 1)and homocysteine in android obesity and the phenomenon of insulin resistance syndromes[J].Vnitr Lek,1999,45(1):11-16.
5BARBORA V,CHRISTIAN W,ROBERT S,et al.High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes[J].Diabetes,2002,51(2):455-461.
6JOHM A,CALDWELL N D.Inflammation and diabetic vascular complications[J].Diabetes Care,1999,22(12):1927-1928.
7NISHIE Y,KASHIWAGI A.Molecular mechanism of endothelial dysfunction in diabetes mellitus[J].Nippon Rinsho,2001,59(12):2451-2459.
8PICKUP J C,MATTOCK M B,CHUSNEY G D,et al.NIDDM as disease of the innate immune system: association of acute reactants and interleukin-6 with metabolic syndrome X[J].Diabetologia,1997,40(11):1286-1292.
9Cabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med, 1999,340:448-454.
10Donald E. Increased levels of acute-phase serum proteins in diabetes. Metabolism, 1989,38:1042-1046.
